(PR1J) Amundi Prime Japan DR (D) - Ratings and Ratios
Japan Stocks, Large Cap Stocks, Equity Funds
Description: PR1J Amundi Prime Japan DR (D) July 16, 2025
The Amundi Prime Japan UCITS ETF DR (D) is an exchange-traded fund (ETF) listed on XETRA, tracking the Morningstar Japan TME NR JPY index. As a Japan Large-Cap Blend Equity ETF, it provides diversified exposure to the Japanese equity market, focusing on large-cap stocks.
With Assets Under Management (AUM) of approximately €177.46 billion, this ETF is one of the larger players in the Japan Large-Cap Blend Equity category, suggesting a high level of investor confidence and liquidity. The funds size can contribute to lower expense ratios and tighter bid-ask spreads, making it an attractive option for investors seeking to gain exposure to the Japanese market.
To further evaluate the ETFs performance, key metrics such as tracking error, expense ratio, and dividend yield should be considered. A low tracking error would indicate that the ETF is effectively replicating the performance of its underlying index. The expense ratio, which represents the funds operating expenses as a percentage of its AUM, is crucial in assessing the cost-efficiency of the investment. Additionally, the dividend yield can provide insights into the income generated by the ETF, which is particularly relevant for income-focused investors.
From a quantitative perspective, analyzing the ETFs historical returns, Sharpe ratio, and beta can offer valuable insights into its risk-adjusted performance and volatility relative to the broader market. The Sharpe ratio, in particular, can help investors understand the ETFs excess returns relative to its risk, while the beta can provide insights into its systematic risk. By examining these KPIs, investors can make more informed decisions about the suitability of the Amundi Prime Japan UCITS ETF DR (D) for their investment portfolios.
PR1J ETF Overview
| Market Cap in USD | 379,356m |
| Category | Japan Large-Cap Blend Equity |
| TER | 0.05% |
| IPO / Inception | 2019-01-30 |
PR1J ETF Ratings
| Growth Rating | 68.0% |
| Fundamental | - |
| Dividend Rating | 55.3% |
| Return 12m vs S&P 500 | -6.02% |
| Analyst Rating | - |
PR1J Dividends
| Dividend Yield 12m | 1.69% |
| Yield on Cost 5y | 2.68% |
| Annual Growth 5y | 7.03% |
| Payout Consistency | 97.7% |
| Payout Ratio | % |
PR1J Growth Ratios
| Growth Correlation 3m | 80.9% |
| Growth Correlation 12m | 53.4% |
| Growth Correlation 5y | 77.5% |
| CAGR 5y | 12.91% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.79 |
| CAGR/Mean DD 3y (Pain Ratio) | 4.28 |
| Sharpe Ratio 12m | -0.45 |
| Alpha | 2.30 |
| Beta | 0.000 |
| Volatility | 17.02% |
| Current Volume | 1.8k |
| Average Volume 20d | 5.9k |
| Stop Loss | 30.9 (-3.2%) |
| Signal | 0.11 |
What is the price of PR1J shares?
Over the past week, the price has changed by +2.27%, over one month by +1.56%, over three months by +6.96% and over the past year by +12.76%.
Is Amundi Prime Japan DR (D) a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PR1J is around 31.74 EUR . This means that PR1J is currently overvalued and has a potential downside of -0.6%.
Is PR1J a buy, sell or hold?
What are the forecasts/targets for the PR1J price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.5 | 11.3% |
PR1J Fundamental Data Overview January 01, 1970
Market Cap EUR = 324.15b (324.15b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 324.15b EUR (324.15b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 324.15b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 324.15b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(324.15b)/V(0.0) * Re(8.48%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)